GlassScriptPhysician profile
Marcela A Lazo
NPI 1629262126
$750.60
in general payments reported to CMS, 2019-2025
16 companies · $10.28 in 2025
The $10.28 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $412 · 2020: $169 · 2021: $90.15 · 2023: $13.15 · 2024: $56.02 · 2025: $10.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $281.73 | 2019-2021 | |
| Hologic Sales and Service, LLC | $80.84 | 2019-2020 | |
| Boston Scientific Corporation | $61.96 | 2021-2024 | Wavewriter Alpha Prime 16 |
| Allergan, INC. | $55.97 | 2019 | |
| Roche Diagnostics Corporation | $45.53 | 2021 | |
| Therapeuticsmd, INC. | $37.30 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $32.70 | 2020 | |
| Organon LLC | $25.44 | 2024-2025 | Jada System |
| Fujifilm New Development USA, INC. | $24.61 | 2019 | |
| Lupin INC. | $18.95 | 2020 | |
| Radius Health, INC. | $16.17 | 2019 | |
| Aspira Women'S Health INC | $15.71 | 2020 | |
| Pfizer INC. | $14.98 | 2019 | |
| Exeltis, USA INC. | $13.31 | 2020 | |
| Coopersurgical, INC. | $13.15 | 2023 | Summit Doppler |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $12.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcela Lazo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.